BlackRock »

Lineage Cell Therapeutics In shares owned by BlackRock

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.0M 9.9M 0.91

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Lineage Cell Therapeutics In

BlackRock
BlackRock
Vanguard Group
Defender Capital
Logos Global Management
Raffles Associates
Geode Capital Management
State Street Corporation
MAI Wealth Advisors
Bank of America Corporation
DAFNA Capital Management
Northern Trust
Bridgeway Capital Management
Jpmorgan Chase & Co
Morgan Stanley

View all funds holding Lineage Cell Therapeutics In